On Thursday, April 28, at 12:30 PM ET, please join Gene Quinn, President & CEO of IPWatchdog, Inc., and our distinguished panel consisting of Dr. Stephen Byrn of Purdue University and Improved Pharma, Dr. Steven Zeman, partner and European and German patent attorney at the firm Grünecker Patent Attorneys and Attorneys at Law in Munich, Germany, and Eyal Barash, a U.S. Patent attorney from Barash Law, LLC, for this webinar on patenting pharmaceutical salts. The panel will focus on questions related to obviousness and inventive step, enablement and written description sufficiency, and scientific aspects of pharmaceutical salts. The panel will further address issues related to litigation of patents directed to such salts from both a legal and expert witness point of view.
